Online first
Research paper
Published online: 2024-10-23

open access

Page views 133
Article views/downloads 85
Get Citation

Connect on Social Media

Connect on Social Media

Associations vulvar lichen sclerosus with autoimmune thyroid diseases

Maja J. Zieba-Domalik1, Dominika Orszulak1, Kacper Nizinski1, Katarzyna Wilk1, Marta Janik2, Rafal Stojko1, Agnieszka Drosdzol-Cop1

Abstract

Objectives: Vulvar lichen sclerosus (VLS) is defined as a chronic inflammatory skin disease that most often involves lesions on the mucous membranes of the vulva with a tendency to progress to the anal skin. The etiopathogenesis of VLS remains unknown and is likely multifactorial. Data emphasize the role of immunological factors — more than 25% of VLS cases coexist with autoimmune diseases. The purpose of the present study was to determine the correlation of the prevalence of anti-thyroid antibodies — IgG class antibodies against thyroid peroxidase and IgG class antibodies against thyroglobulin in women with vulvar lichen sclerosus, and the appropriateness of screening tests for autoimmune thyroid diseases in women with vulvar lichen sclerosus. Material and methods: Fifty women with vulvar lichen sclerosus were enrolled in the study. The control group consisted of 41 healthy women. A detailed medical history was taken with all patients, followed by laboratory determinations — anti-thyroid antibodies — IgG class antibodies against thyroid peroxidase and IgG class antibodies against thyroglobulin. Results: Antibodies to thyroid peroxidase were present in 12% of the study group with vulvar lichen sclerosus and 4.88% of the control group, and this difference was not statistically significant (p = 0.41). Anti-thyroglobulin antibodies were detected in 4% of the patients with vulvar lichen sclerosus and 4.88% of the control group, and this difference was not statistically significant either (p = 0.76). Conclusions: The study did not confirm the association of VLS with autoimmune thyroid diseases. Undoubtedly, based on the data available in the literature, further studies are needed to determine the mechanisms behind the association between vulvar lichen sclerosus and autoimmune thyroid diseases.

Article available in PDF format

View PDF Download PDF file

References

  1. Kirtschig G, Cooper S, Aberer W, et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol. 2015; 29(10): e1–43.
  2. Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Number 224. Obstet Gynecol. 2020; 136(1): 222–225.
  3. Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010; 163(4): 672–682.
  4. Khan Mohammad Beigi P. The Immunogenetics of Morphea and Lichen Sclerosus. Adv Exp Med Biol. 2022; 1367: 155–172.
  5. Kirby L, Gran S, Orekoya F, et al. Is urinary incontinence associated with vulval lichen sclerosus in women? A cross-sectional study. Br J Dermatol. 2021; 185(5): 1063–1065.
  6. Orszulak D, Dulska A, Niziński K, et al. Pediatric Vulvar Lichen Sclerosus-A Review of the Literature. Int J Environ Res Public Health. 2021; 18(13).
  7. De Luca DA, Papara C, Vorobyev A, et al. Lichen sclerosus: The 2023 update. Front Med (Lausanne). 2023; 10: 1106318.
  8. Drosdzol-Cop A, Orszulak D. Pediatric and Adolescent Gynecology - diagnostic and therapeutic trends. Ginekol Pol. 2022; 93(12): 939–940.
  9. Nizinski K, Orszulak D, Janik M, et al. The analysis of coexistence of celiac disease and vulvar lichen sclerosus in girls. Ginekol Pol. 2022; 93(10): 793–798.
  10. Goolamali SK, Barnes EW, Irvine WJ, et al. Organ-specific antibodies in patients with lichen sclerosus. Br Med J. 1974; 4(5936): 78–79.
  11. Cooper SM, Ali I, Baldo M, et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008; 144(11): 1432–1435.
  12. Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013; 93(2): 238–241.
  13. Fan R, Leasure AC, Maisha FI, et al. Thyroid disorders associated with lichen sclerosus: a case-control study in the All of Us Research Program. Br J Dermatol. 2022; 187(5): 797–799.
  14. Bieber AK, Steuer AB, Melnick LE, et al. Autoimmune and dermatologic conditions associated with lichen sclerosus. J Am Acad Dermatol. 2021; 85(1): 228–229.
  15. Kazandi M, Sahin C, Terek MC, et al. Clinical evaluation of vulvar lichen sclerosus: case series. Eur J Gynaecol Oncol. 2010; 31(5): 555–558.
  16. Birenbaum DL, Young RC. High prevalence of thyroid disease in patients with lichen sclerosus. J Reprod Med. 2007; 52(1): 28–30.
  17. Azevedo MS, Chambo Filho A, Diniz LM, et al. Prevalence of the association of vulvar lichen sclerosis with Hashimoto's thyroiditis. An Bras Dermatol. 2024; 99(3): 445–447.
  18. Guarneri F, Giuffrida R, Di Bari F, et al. Thyroid Autoimmunity and Lichen. Front Endocrinol (Lausanne). 2017; 8: 146.
  19. Sivalingam V, Tamber K. Understanding the impact of life with vulval lichen sclerosus. Br J Dermatol. 2022; 187(6): 840.
  20. Arnold S, Fernando S, Rees S. Living with vulval lichen sclerosus: a qualitative interview study. Br J Dermatol. 2022; 187(6): 909–918.
  21. Jabłonowska O, Woźniacka A, Szkarłat S, et al. Female genital lichen sclerosus is connected with a higher depression rate, decreased sexual quality of life and diminished work productivity. PLoS One. 2023; 18(4): e0284948.
  22. Yıldız Ş, Cengiz H, Kaya C, et al. Evaluation of genital self-image and sexual dysfunction in women with vulvar lichen planus or lichen sclerosus. J Psychosom Obstet Gynaecol. 2022; 43(2): 99–106.